Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SGNT

(SGNT) (SGNT) Stock Price, News & Analysis

(SGNT) logo

About (SGNT) Stock (NASDAQ:SGNT)

Advanced Chart

Key Stats

Today's Range
$21.76
$21.76
50-Day Range
N/A
52-Week Range
$10.55
$21.88
Volume
N/A
Average Volume
607,514 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Sagent Pharmaceuticals, Inc. is a specialty and generic pharmaceutical company. The Company is a provider of pharmaceuticals to the hospital market, which it sells primarily throughout North America. It is focused on developing, manufacturing, sourcing and marketing injectable pharmaceutical products to the hospital market. It operates through two segments: Sagent US, consisting of the Company's operations in the United States and the Sagent (China) Pharmaceuticals Co. Ltd. (SCP) manufacturing facility, and Omega, which is focused on the Canadian and international markets. It offers a range of products across anti-infective, oncology and critical care indications in a range of presentations, including single and multi-dose vials, pre-filled ready-to-use syringes and premix bags. Its Sagent US product portfolio includes approximately 60 marketed products that it offers in over 180 presentations, and its Omega segment offers over 50 products.

Receive SGNT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (SGNT) and its competitors with MarketBeat's FREE daily newsletter.

SGNT Stock News Headlines

Elon just did WHAT!?
As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they gotten away with it, the Fed and U.S. banks could have seized control of our financial lives forever. But Trump stopped them cold on January 23rd, 2025, when he outlawed CBDCs… Paving the way for Elon Musk's secret master plan.
See More Headlines

SGNT Stock Analysis - Frequently Asked Questions

(SGNT) (NASDAQ:SGNT) posted its quarterly earnings data on Tuesday, August, 4th. The company reported ($0.01) earnings per share for the quarter, missing the consensus estimate of $0.05 by $0.06. The company's quarterly revenue was up 11.7% on a year-over-year basis.

Based on aggregate information from My MarketBeat watchlists, some other companies that (SGNT) investors own include Mazor Robotics (MZOR), SELLAS Life Sciences Group (SLS), Allena Pharmaceuticals (ALNA), Advanced Micro Devices (AMD), Chatham Lodging Trust (CLDT), CTI BioPharma (CTIC) and Idera Pharmaceuticals (IDRA).

Company Calendar

Last Earnings
8/04/2015
Today
5/10/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
N/A
Industry
N/A
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:SGNT
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

This page (NASDAQ:SGNT) was last updated on 5/10/2025 by MarketBeat.com Staff
From Our Partners